Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review

Review Article
First Online:

Abstract

Inflammatory bowel disease (IBD) is a chronic illness with periods of varying disease activity called flares and remissions. Since IBD impacts quality of life, patients make IBD disease management decisions every day. Previous research indicates limited insight about factors that influence decisions regarding disease management and the types of decisions IBD patients make. The purpose of this integrative review is to identify types of treatment and non-treatment decisions and the factors that influence decision making regarding disease management among individuals with IBD. An integrative literature review was performed based on the Whittemore and Knafl framework. PubMed, Web of Science, and PsychINFO were searched for relevant articles, from 2010–2016, using the key terms: decision making, patient preferences, self-management, self-care, nutrition, diet, stress, symptom, Colitis, Crohns, and IBD. Twenty-eight articles met the inclusion criteria. From these, research showed two types of decisions: treatment decisions related to medication and surgery, and non-treatment decisions focused on diet modification. Five themes that influence decisions were identified: experiencing symptoms, provider recommendations, convenience attributes, psychosocial factors, and informational needs. Most of the studies found a positive relationship between an increased number of symptoms and a patient’s willingness to engage in treatment decisions. Although support from providers is highly influential for treatment decisions, most studies reported that provider recommendations did not align with patient preferences. Future work is needed to understand factors that influence decisions among recently diagnosed patients, to focus on non-treatment-related decisions, and to clarify the role of psychosocial factors in promoting disease decision making among IBD patients. This integrative review identified that, for patients, experiencing symptoms is the most important factor that influences treatment and non-treatment decisions.

This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

Dr. Barbara Given critically reviewed and provided feedback on the draft manuscript.

Compliance with Ethical Standards

Kendra Kamp obtained funding for this project from the Jonas Foundation, Michigan State University College of Nursing, George and Margaret Lorimer Parsons Nursing Endowed Scholarship, and the William and Angeline Keehner Scholarship. Kendra has no conflicts of interests to disclose. Kelly Brittain has no conflicts of interests to disclose.

Supplementary material

40271_2017_294_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (DOCX 15 kb)

References

  1. 1.
    Crohn’s and Colitis Foundation of America. Managing flares and other IBD symptoms. New York: Crohn’s and Colitis Foundation of America; 2009.Google Scholar
  2. 2.
    Crohn’s and Colitis Foundation of America. The facts about inflammatory bowel diseases. New York: Crohn’s and Colitis Foundation of America; 2015.Google Scholar
  3. 3.
    Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther. 2016;7(1):5–20.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ye Y, et al. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015;8(12):22529–42.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Jedel S, et al. A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion. 2014;89(2):142–55.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(1):164–70.CrossRefPubMedGoogle Scholar
  7. 7.
    Grey M, et al. A revised self- and family management framework. Nurs Outlook. 2015;63(2):162–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Ryan P, Sawin KJ. The individual and family self-management theory: background and perspectives on context, process, and outcomes. Nurs Outlook. 2009;57(4):217–25.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kaplan GG. The global burden of IBD: from 2015 to 2025. Nature Reviews. Gastroenterol Hepatol. 2015;12(12):720–7.Google Scholar
  10. 10.
    Herman ML, Kane SV. Treatment nonadherence in inflammatory bowel disease: identification, scope, and management strategies. Inflamm Bowel Dis. 2015;21(12):2979–84.CrossRefPubMedGoogle Scholar
  11. 11.
    Higgins PD, et al. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009;29(3):247–57.CrossRefPubMedGoogle Scholar
  12. 12.
    Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–53.CrossRefPubMedGoogle Scholar
  13. 13.
    Rini C, et al. Interpersonal influences on patients’ surgical decision making: the role of close others. J Behav Med. 2011;34(5):396–407.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kahn SA, et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013;19(7):1506–13.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Allison M, et al. Surgery in young adults with inflammatory bowel disease: a narrative account. Int J Nurs Stud. 2013;50(11):1566–75.CrossRefPubMedGoogle Scholar
  16. 16.
    Byrne CM, et al. Patient and clinician preferences for surgical and medical treatment options in Ulcerative Colitis. Colorectal Dis. 2014;16(4):285–92.CrossRefPubMedGoogle Scholar
  17. 17.
    Siegel CA, et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010;16(10):1658–62.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Brown LK, et al. Proximity to disease and perception of utility: physicians’ vs patients’ assessment of treatment options for ulcerative colitis. Dis Colon Rectum. 2011;54(12):1529–36.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Bewtra M, et al. Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):103–14.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lichtenstein G, et al. Assessing drug treatment preferences of patients with Crohn’s Disease. Patient: Patient-Cent Outcomes Res. 2010;3(2):113–23.CrossRefGoogle Scholar
  21. 21.
    Vavricka SR, et al. Systematic assessment of factors influencing preferences of Crohn’s disease patients in selecting an anti-tumor necrosis factor agent (Choose TNF trial). Inflamm Bowel Dis. 2012;18(8):1523–30.CrossRefPubMedGoogle Scholar
  22. 22.
    Kim ES, et al. Factors contributing to the preference of Korean patients with Crohn’s disease when selecting an anti-tumor necrosis factor agent (CHOICE Study). Gut Liver. 2016;10(3):391–8.PubMedGoogle Scholar
  23. 23.
    Hodgkins P, et al. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment. Patient. 2012;5(1):33–44.CrossRefPubMedGoogle Scholar
  24. 24.
    Peyrin-Biroulet L, et al. Patient perspectives on biosimilars: a survey by the European Federation of Crohn’s and Ulcerative Colitis associations. J Crohns Colitis. 2017;11(1):128–33.CrossRefPubMedGoogle Scholar
  25. 25.
    Bewtra M, Johnson FR. Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient. 2013;6(4):241–55.CrossRefPubMedGoogle Scholar
  26. 26.
    Casellas F, et al. Patient preferences for inflammatory bowel disease treatment objectives. Dig Liver Dis. 2017;49(2):152–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Peyrin-Biroulet L, et al. Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: a real world-based study. Dig Liver Dis. 2016;48(6):601–7.CrossRefPubMedGoogle Scholar
  28. 28.
    van Deen WK, et al. Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients’ preferences. Qual Life Res. 2017;26(2):455–65.CrossRefPubMedGoogle Scholar
  29. 29.
    Carpio D, et al. Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey. Eur J Gastroenterol Hepatol. 2016;28(9):1056–64.CrossRefPubMedGoogle Scholar
  30. 30.
    Siegel CA, et al. Novel statistical approach to determine inflammatory bowel disease: patients’ perspectives on shared decision making. Patient. 2016;9(1):79–89.CrossRefPubMedGoogle Scholar
  31. 31.
    Kemp K, et al. An exploration of the follow-up up needs of patients with inflammatory bowel disease. J Crohns Colitis. 2013;7(9):e386–95.CrossRefPubMedGoogle Scholar
  32. 32.
    Vagianos K, et al. What are adults with inflammatory bowel disease (IBD) eating? A closer look at the dietary habits of a population-based Canadian IBD Cohort. J Parenter Enteral Nutr. 2016;40(3):405–11.CrossRefGoogle Scholar
  33. 33.
    Zallot C, et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19(1):66–72.CrossRefPubMedGoogle Scholar
  34. 34.
    Schreiber S, et al. Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterol. 2012;12:108.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Thompson KD, et al. Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications. Inflamm Bowel Dis. 2016;22(4):940–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Bernstein KI, et al. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(2):590–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Pittet V, et al. Information needs and concerns of patients with inflammatory bowel disease: what can we learn from participants in a bilingual clinical cohort? PLoS One. 2016;11(3):e0150620.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Wong S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Can J Gastroenterol. 2012;26(8):525–31.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Johnson FR, et al. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn’s disease management. J Manag Care Pharm. 2010;16(8):616–28.PubMedGoogle Scholar
  40. 40.
    Keefer L, Kane S. Self-management techniques in IBD. In: Cross RK, Watson AR, editors. Telemanagement of inflammatory bowel disease. Berlin: Springer; 2016. p. 55–70.CrossRefGoogle Scholar
  41. 41.
    Khanna R, et al. Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database Syst Rev. 2016;8:Cd010642.Google Scholar
  42. 42.
    Novak K, et al. Clinic-based point of care transabdominal ultrasound for monitoring Crohn’s disease: impact on clinical decision making. J Crohns Colitis. 2015;9(9):795–801.CrossRefPubMedGoogle Scholar
  43. 43.
    Walsh AJ, Bryant RV, Travis SPL. Current best practice for disease activity assessment in IBD. Nat Rev Gastroenterol Hepatol. 2016;13(10):567–79.CrossRefPubMedGoogle Scholar
  44. 44.
    Muhlbacher AC, Juhnke C. Patient preferences versus physicians’ judgement: does it make a difference in healthcare decision making? Appl Health Econ Health Policy. 2013;11(3):163–80.CrossRefPubMedGoogle Scholar
  45. 45.
    Goldberg HB, Shorten A. Differences between patient and provider perceptions of informed decision making about epidural analgesia use during childbirth. J Perinat Educ. 2014;23(2):104–12.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Tanaka M, et al. Coping strategies for possible flare-ups and their perceived effectiveness in patients with inflammatory bowel disease. Gastroenterol Nurs. 2016;39(1):42–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Cohan JN, et al. A novel decision aid for surgical patients with ulcerative colitis: results of a pilot study. Dis Colon Rectum. 2016;59(6):520–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Baker DM, et al. A systematic review of internet decision-making resources for patients considering surgery for ulcerative colitis. Inflamm Bowel Dis. 2017;23(8):1293–300.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Michigan State UniversityEast LansingUSA

Personalised recommendations